about
Selective vasopressin type 2 receptor antagonist for patients with cirrhosisAntibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleedingBariatric surgery for non-alcoholic steatohepatitis in obese patientsImage-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscessBariatric surgery for non-alcoholic steatohepatitis in obese patientsRole of bioactive fatty acids in nonalcoholic fatty liver diseaseMitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachHerbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical ReviewGranulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysisSerum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.Metabolic syndrome as a risk factor for gallstone disease.Low serum levels of ghrelin are associated with gallstone disease.Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator.Rhombencephalitis by Listeria monocytogenes in a cirrhotic patient: a case report and literature review.Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.Endoscopic submucosal dissection in dogs in a World Gastroenterology Organisation training centerClinical heterogeneity in autoimmune acute liver failureThe Amerindian's genes in the Mexican population are associated with development of gallstone disease.Adiponectin as a protective factor in hepatic steatosis.The role of dietary fats in the pathogenesis of gallstones.Nuclear receptors in nonalcoholic Fatty liver diseaseHepatic encephalopathy: a review.Alcoholic liver disease. An update.Effects of leptin on biliary lipids: potential consequences for gallstone formation and therapy in obesity.Biliary stricture caused by portal biliopathy: case report and literature review.Beta blockers in portal hypertension. Are they really a good option?Current concepts in the pathogenesis of nonalcoholic fatty liver disease.Hepatobiliary diseases and insulin resistance.A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy.Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.Non-alcoholic fatty-liver disease in pediatric populations.The molecular basis of susceptibility to infection in liver cirrhosis.Intestinal flora, probiotics, and cirrhosis.Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease.Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patients.Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.Autoimmune hepatitis with giant-cell transformation.Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.Diagnostic accuracy of nodular gastritis for H. pylori infection.
P50
Q24234739-88EA2FF0-B28F-4580-A0BA-B6F15E2A6E51Q24235526-AB5F846F-443B-4E7A-A5B0-AB46623CC237Q24240455-C3894DE5-408C-4462-BBE3-489421F08E47Q24241178-680EA79C-CD21-406B-BB95-238220578337Q24242858-0EFB7D79-7FED-4C72-97E3-36AF538A10D0Q26739904-4380F1DA-2C14-4BAB-AEAD-008AA4487AB9Q26753043-0336580B-70DA-40DE-BAB1-87DB33C7AE46Q26764922-F90D92E0-3972-41E9-B4F5-53EA00238584Q26800374-E30A3CC4-79C7-42A5-9433-92FC23C51029Q30411805-C3629304-3570-40F2-98BD-450A84CA90A1Q30420193-B3DB9C12-3047-49FC-8C53-138EA4E8F549Q30433017-524F7D16-A25F-4A3D-B24A-F502C8A55E07Q30457278-CCC7AC35-AB1F-4339-8F9E-1B5D89F13FA3Q30665774-CE1DD4B3-865D-4EFD-8280-8CB3F7C37841Q33268183-7413EC94-0929-4DF7-A23B-93A334716F36Q33782071-2BF84DE9-5E06-4FDC-A012-1E0FC0BDD32CQ34112226-C300A5C0-47CF-4AE7-9ABB-095ECDAECF69Q34369622-763417C6-EFA1-4709-A29C-85C13FC66734Q35011045-C1B8A940-E0AF-40F5-96EE-10DE32AC5B62Q35109598-1CECFDC5-9132-44ED-BB05-9848CBD4F7BEQ35609154-EA6A5FEE-0DBE-402E-9881-E7FCCEBEA597Q35759484-496BCFE8-772E-4885-B55E-29EDB43A62E6Q36083922-45537D25-C936-4D2C-8C28-0C1BE0FC70ACQ36223469-388E5F61-7F13-4D84-9BC3-724926A98695Q36375975-59A0CC83-5903-4245-AC57-B0456B3F165AQ36522855-BB7360FF-938A-4329-94F5-7E4726C8E8ABQ36777932-E75E5B11-A4B3-48E5-B8DF-9BCD825BE539Q36907292-5F2C72C5-D190-46BC-85F9-0B5DB01E73C9Q36945543-B647E994-DEF5-43E1-A7F0-565222290558Q37002768-541940EC-7F61-4D38-88B8-94B8150A9702Q37021138-ADF877AB-7FF7-4795-9A11-5F2F2AD9115AQ37066027-72A7B6A3-65AA-4B0A-81A4-13E32546CA4AQ37216278-2FD7CA53-4A9C-40CE-BC63-437E75B2F66EQ37255005-614BDF1C-50FF-4F05-B658-06FC06D6F838Q37267292-CE666B64-4542-48C4-B2FD-065A5F44EB75Q37336398-AA28CF2F-5ADE-422C-B332-61B7F9EBF754Q37341341-1E980F70-FC83-470D-82F9-88498636EC58Q37394580-C7FDBD6D-80F5-4FA6-AC5E-33F6F2E150DDQ37511212-EF4F4C3A-C099-466B-95B6-BA990CA1A8DEQ37527849-68D77D06-31DD-4079-94F8-F18D7BB657E1
P50
description
onderzoeker
@nl
name
Misael Uribe
@ast
Misael Uribe
@en
Misael Uribe
@es
Misael Uribe
@sl
type
label
Misael Uribe
@ast
Misael Uribe
@en
Misael Uribe
@es
Misael Uribe
@sl
prefLabel
Misael Uribe
@ast
Misael Uribe
@en
Misael Uribe
@es
Misael Uribe
@sl